Photodiagnosis and Photodynamic Therapy
Volume 6, Issue 2 , Pages 105-116 , June 2009

In vitro efficiency and mechanistic role of indocyanine green as photodynamic therapy agent for human melanoma

  • Abdel-Megid Mamoon

      Affiliations

    • Egyptian Atomic Energy Authority, Nasr City, Cairo, Egypt
    • ,
  • Amira M. Gamal–Eldeen

      Affiliations

    • Cancer Biology Laboratory, Center of Excellence for Advanced Sciences, National Research Center, Dokki 12622, Cairo, Egypt
    • Cancer Biology Laboratory, Center of Excellence for Advanced Sciences, National Research Center, Dokki 12622, Cairo, Egypt. Tel.: +2 010 605 3903; fax: +2 02 333 709 31.
    • ,
  • Meghan E. Ruppel

      Affiliations

    • Department of Biomedical Engineering, Stony Brook University, Stony Brook, NY, 11794, USA
    • ,
  • Randy J. Smith

      Affiliations

    • National Synchrotron Light Source, Brookhaven National Laboratory, Upton, NY, 11973, USA
    • ,
  • Thomas Tsang

      Affiliations

    • Instrumentation Division, Brookhaven National Laboratory, Upton, NY, 11973, USA
    • ,
  • Lisa M. Miller, MS PhD

      Affiliations

    • Department of Biomedical Engineering, Stony Brook University, Stony Brook, NY, 11794, USA
    • National Synchrotron Light Source, Brookhaven National Laboratory, Upton, NY, 11973, USA
    • Corresponding Author InformationCorresponding author at: National Synchrotron Light Source, Bldg 725 D, Brookhaven National Laboratory, 75 Brookhaven Avenue, Upton, NY 11973-5000, USA. Tel.: +1 631 344 2091; fax: +1 631 344 3238.

References 

  1. Triesscheijn M, Baas P, Schellens JHM, Stewart FA. Photodynamic therapy in oncology. Oncologist. 2006;11:1034–1044
  2. Foote CS. Definition of type I and type II photosensitized oxidation. Photochem Photobiol. 1991;54:659–664
  3. Henderson BW, Gollnick SO, Snyder JW, et al. Choice of oxygen-conserving treatment regimen determines the inflammatory response and outcome of photodynamic therapy of tumors. Cancer Res. 2004;64:2120–2126
  4. Dougherty TJ, Kaufman JE, Goldfarb A, Weishaupt KR, Boyle D, Mittleman A. Photoradiation therapy for the treatment of malignant tumors. Cancer Res. 1978;38:2628–2635
  5. Kelly JF, Snell ME. Hematoporphyrin derivative; a possible aid in the diagnosis and therapy of carcinoma of the bladder. J Urol. 1976;115:150–151
  6. Rhodes LE, de Rie M, Enstrom Y, et al. Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma; results of a multicenter randomized prospective trial. Arch Dermatol. 2004;140:17–23
  7. Taub AF. Photodynamic therapy in dermatology: history and horizons. J Drugs Dermatol. 2004;3:S8–S25
  8. Fijan S, Honigsmann H, Ortel B. Photodynamic therapy of epithelial skin tumours using delta-aminolaevulinic acid and desferrioxamine. Br J Dermatol. 1995;133:282–288
  9. Soler AM, Angell-Petersen E, Warloe T, et al. Photodynamic therapy of superficial basal cell carcinoma with 5-aminolevulinic acid with dimethylsulfoxide and ethylendiaminetetraacetic acid: a comparison of two light sources. Photochem Photobiol. 2000;71:724–729
  10. Morton CA, Whitehurst C, Moseley H, McColl JH, Moore JV, Mackie RM. Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's disease. Br J Dermatol. 1996;135:766–771
  11. Zeitouni NC, Shieh S, Oseroff AR. Laser and photodynamic therapy in the management of cutaneous malignancies. Clin Dermatol. 2001;19:328–338
  12. Baas P, Saarnak AE, Oppelaar H, Neering H, Stewart FA. Photodynamic therapy with metatetrahydroxyphenylchlorin for basal cell carcinoma: a phase I/II study. Br J Dermatol. 2001;145:75–78
  13. Dougherty TJ. Photosensitizers: therapy and detection of malignant tumors. Photochem Photobiol. 1987;45:879–889
  14. Kukielczak B, Cieszka KA, Matuszak ZT, Subczynski WK. Experimental photodynamic therapy of Bomirski hamster melanoma using merocyanine 540 and visible light. Curr Topics Biophys. 1995;19:6–70
  15. Chedekel MR. Photophysics and photochemistry of melanin. In:  Zeise L,  Chedekel MR,  Fitzpatrick TB editor. Melanin: its role in human photoprotection. Overland Park, KS: Valdenmar Publ. Co.; 1995;p. 11–21
  16. Baumler W, Abels C, Karrer S, et al. Photo-oxidative killing of human colonic cancer cells using indocyanine green and infrared light. Br J Cancer. 1999;80:360–363
  17. Wilson BC, Jeeves WP, Lowe DM. In vivo and post mortem measurements of the attenuation spectra of light in mammalian tissues. Photochem Photobiol. 1985;42:153–162
  18. Liggett PE, Lavaque AJ, Chaudhry NA, Jablon EP, Quiroz-Mercado H. Preliminary results of combined simultaneous transpupillary thermotherapy and ICG-based photodynamic therapy for choroidal melanoma. Ophthalmic Surg Lasers Imaging. 2005;36:463–470
  19. Stoffelns BM. Kinetics of indocyanine green (ICG) and clinical use for enhancement of transpupillary thermotherapy (TTT) in hypopigmented small choroidal melanomas. Klin Monatsbl Augenheilkd. 2004;221:374–378
  20. Kubicka-Trzaska A, Starzycka M, Romanowska-Dixon B, Morawski K. Use of indocyanine green for photodynamic therapy of choroidal melanoma—preliminary report. Klin Oczna. 2003;105:132–135
  21. De Potter P, Jamart J. Adjuvant indocyanine green in transpupillary thermotherapy for choroidal melanoma. Ophthalmology. 2003;110:406–413
  22. Murillo López SA, Suárez Tata LM, Sinisterra Pava JP, García Aguirre JG, Quiroz Mercado H, Liggett Peter E. Choroidal melanoma treated with 810nm diode laser and indocyanine green. A case report. Arch Soc Esp Oftalmol. 2002;77:567–570
  23. Chong LP, Ozler SA, de Queiroz JM, Liggett PE. Indocyanine green-enhanced diode laser treatment of melanoma in a rabbit model. Retina. 1993;13:251–259
  24. Urbanska K, Romanowska-Dixon B, Matuszak Z, Oszajca J, Nowak-Sliwinsk P, Stochel G. Indocyanine green as a prospective sensitizer for photodynamic therapy of melanomas. Acta Biochim Pol. 2002;49:387–391
  25. Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W. Current protocols in immunology. In:  Coico R editors. Related isolation procedures and functional assays. vol. 1:John Wiley & Sons, Inc.; 1995;3.17.1
  26. Ribble D, Goldstein NB, Norris DA, Shellman YG. A simple technique for quantifying apoptosis in 96-well plates. BMC Biotechnol. 2005;10:5–12
  27. Smith PK, Krohn RI, Hermanson GT, et al. Measurement of protein using bicinchoninic acid. Anal Biochem. 1985;150:76–85
  28. MeBmer UK, Reed JC, Brue NEB. Bcl-2 protects macrophages from nitric oxide-induced apoptosis. J Biol Chem. 1998;271:20192–20197
  29. Burton K. A study of the conditions and mechanisms of the diphenylamine reaction for the estimation of deoxyribonucleic acid. Biochem J. 1956;62:315–323
  30. Holman HY, Goldstein RG, Martin MC, Russell ML, Mckinney WR. Low dose responses to 2,3,7,8-tetrachlorodibenzo-p-dioxin in single living human cells measured by synchrotron infrared spectromicroscopy. Environ Sci Technol. 2000;34:2513–2517
  31. Holman HY, Martin MC, Blakely EA, Bjornstad K, Mckinney WR. IR spectromicroscopic characteristics of cell cycle and cell death probed by synchrotron radiation based Fourier transform IR spectromicroscopy. Biopolymers (Biospectroscopy). 2000;57:325–329
  32. Holman HY, Bjornstad KA, McNamara MP, Martin MC, Mckinney WR, Blakely EA. Synchrotron infrared spectromicroscopy as a novel bioanalytical microprobe for individual living cells: cytotoxicity considerations. J Biomed Optics. 2002;7:417–424
  33. Jamin N, Miller L, Moncuit J, Fridman WH, Dumas P, Teillaud JL. Chemical heterogeneity in cell death: combined synchrotron IR and fluorescence microscopy studies of single apoptotic and necrotic cells. Biopolymers. 2003;72:366–373
  34. Liu X, Kim CN, Yang J, Jemmerson R, Wang X. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell. 1996;86:147–157
  35. Fiers W, Beyaert R, Declercq W, Vandenabeele P. More than one way to die: apoptosis, necrosis and reactive oxygen damage. Oncogene. 1999;18:7719–7730
  36. Kalka K, Ahmad N, Criswell T, Boothman D, Mukhtar H. Up-regulation of clusterin during phthalocyanine 4 photodynamic therapy mediated apoptosis of tumor cells and ablation of mouse skin tumors. Cancer Res. 2000;60:5984–5987
  37. Lam M, Oleinick NL, Nieminen A-L. Photodynamic therapy-induced apoptosis in epidermoid carcinoma cells. J Biol Chem. 2001;276:47379–47386
  38. Fickweiler S, Szeimies R-M, Baumler W, et al. Indocyanine green: intracellular uptake and phototherapeutic effects in vitro. J Photochem Photobiol B Biol. 1997;38:178–183
  39. Omar GS, Wilson M, Nair SP. Lethal photosensitization of wound-associated microbes using indocyanine green and near-infrared light. BMC Microbiol. 2008;8:111–117
  40. Abels C, Fickweiler S, Weiderer P, et al. Indocyanine green (ICG) and laser irradiation induce photooxidation. Arch Dermatol Res. 2000;292:404–411
  41. Liu KZ, Jia L, Kelsey SM, Newland AC, Mantsch HH. Quantitative determination of apoptosis on leukemia cells by infrared spectroscopy. Apoptosis. 2001;6:269–278
  42. Gasparri F, Muzio M. Monitoring of apoptosis of HL60 cells by Fourier-transform infrared spectroscopy. Biochem J. 2003;369:239–248
  43. Gault N, Poncy JL, Lefaix JL. Radiation-induced apoptosis; a new approach using infrared microspectroscopy. Can J Physiol Pharmacol. 2004;82:38–49
  44. Gault N, Lefaix JL. Infrared microspectroscopic characteristics of radiation-induced apoptosis in human lymphocytes. Radiat Res. 2003;160:238–250
  45. Zhou J, Wang Z, Sun S, Liu M, Zhang HA. rapid method for detecting conformational changes during differentiation and apoptosis of HL60 cells by Fourier-transform infrared spectroscopy. Biotechnol Appl Biochem. 2001;33:127–132
  46. Pozzi D, Grimaldi P, Gaudenzi S, et al. UVB-radiation-induced apoptosis in Jurkat cells: a coordinated fourier transform infrared spectroscopy-flow cytometry study. Radiat Res. 2007;168:698–705
  47. Sternglanz R . Histone acetylation: a gateway to transcriptional activation. Trends Biol Sci. 1996;21:357–358
  48. Walia H, Chen H, Sun JM, Hoith LT, Davie JR. Histone acetylation is required to maintain the unfolded nucleosome structure associated with transcribing DNA. J Biol Chem. 1998;273:14516–14552
  49. Sambucetti LC, Fischer DD, Zabludoff S, et al. Histone deacetylase inhibition selectively alters the activity and expression of cell cycle proteins leading to specific chromatin acetylation and antiproliferative effects. J Biol Chem. 1999;274:34940–34947
  50. Bannister AJ, Miska EA. Regulation of gene expression by transcription factor acetylation. Cell Mol Life Sci. 2000;57:1184–1192
  51. Kouzarides T. Acetylation: a regulatory modification to rival phosphorylation?. EMBO J. 2000;19:1176–1179
  52. Moodie FM, Marwick JA, Anderson CS, et al. Oxidative stress and cigarette smoke alter chromatin remodeling but differentially regulate NF-κB activation and proinflammatory cytokine release in alveolar epithelial cells. FASEB J. 2004;18:1809–1897
  53. Herr I, Debatin KM. Cellular stress response and apoptosis in cancer therapy. Blood. 2001;98:2603–2614
  54. Renno RZ, Delori FC, Holzer RA, Gragoudas ES, Miller JW. Photodynamic therapy using Lu-Tex induces apoptosis in vitro, and its effect is potentiated by angiostatin in retinal capillary endothelial cells. Invest Ophthalmol Vis Sci. 2000;41:3963–3971
  55. Agarwal ML, Clay ME, Harvey EJ, Evans HH, Antunez AR, Oleinick NL. Photodynamic therapy induces rapid cell death by apoptosis in L5178Y mouse lymphoma cell. Cancer Res. 1991;51:5993–5996
  56. Srivastava M, Ahmad N, Gupta S, Mukhtar H. Involvement of Bcl-2 and Bax in photodynamic therapy-mediated apoptosis. Antisense Bcl-2 oligonucleotide sensitizes RIF 1 cells to photodynamic therapy apoptosis. J Biol Chem. 2001;276:15481–15488
  57. Hendrickx N, Volanti C, Moens U, et al. Up-regulation of cyclooxygenase-2 and apoptosis resistance by p38 MAPK in hypericin-mediated photodynamic therapy of human cancer cells. J Biol Chem. 2003;278:52231–52239
  58. Assefa Z, Vantieghem A, Declercqi W, et al. The activation of the c-Jun N-terminal kinase and p38 mitogen-activated protein kinase signaling pathways protects HeLa cells from apoptosis following photodynamic therapy with hypericin. J Biol Chem. 1999;274:8788–8796
  59. Varriale L, Crescenzi E, Paba V, di Celso BM, Palumbo G. Selective light-induced modulation of bcl-XL and bax expressions in indocyanine green-loaded U937 cells: effects of continuous or intermittent photo-sensitization with low IR-light using a 805-nm diode laser. J Photochem Photobiol B. 2000;57:66–75
  60. Crescenzi E, Varriale L, Iovino M, Chiaviello A, Veneziani BM, Palumbo G. Photodynamic therapy with indocyanine green complements and enhances low-dose cisplatin cytotoxicity in MCF-7 breast cancer cells. Mol Cancer Ther. 2004;3:537–544
  61. Ricci F, Pucci S, Sesti F, Missiroli F, Cerulli L, Spagnoli LG. Modulation of Ku70/80, clusterin/ApoJ isoforms and Bax expression in indocyanine-green-mediated photo-oxidative cell damage. Ophthalmic Res. 2007;39:164–173
  62. Genina ÉA , Bashkatov AN, Kochubei VI, Tuchin VV, Al’tshuler GB. The Interaction of indocyanine green dye with the human epidermis studied in vivo. Tech Phys Lett. 2001;27:602–604
  63. Moan I, Berg K. The photodegradation of porphyrins in cells can be used to estimate the lifetime of singlet oxygen. Photochem Photobiol. 1991;53:549–553

PII: S1572-1000(09)00054-4

doi: 10.1016/j.pdpdt.2009.05.002

Photodiagnosis and Photodynamic Therapy
Volume 6, Issue 2 , Pages 105-116 , June 2009

Article Tools

* Image Usage & Resolution